ID   3BP5_HUMAN              Reviewed;         455 AA.
AC   O60239; B3KQW6; Q5JWV9;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   07-APR-2021, entry version 172.
DE   RecName: Full=SH3 domain-binding protein 5;
DE            Short=SH3BP-5;
DE   AltName: Full=SH3 domain-binding protein that preferentially associates with BTK;
GN   Name=SH3BP5; Synonyms=SAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Adrenal gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-455 (ISOFORM 1), FUNCTION, INTERACTION
RP   WITH BTK, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9571151; DOI=10.1006/bbrc.1998.8420;
RA   Matsushita M., Yamadori T., Kato S., Takemoto Y., Inazawa J., Baba Y.,
RA   Hashimoto S., Sekine S., Arai S., Kunikata T., Kurimoto M., Kishimoto T.,
RA   Tsukada S.;
RT   "Identification and characterization of a novel SH3-domain binding protein,
RT   Sab, which preferentially associates with Bruton's tyrosine kinase (Btk).";
RL   Biochem. Biophys. Res. Commun. 245:337-343(1998).
RN   [7]
RP   INTERACTION WITH BTK, AND FUNCTION.
RX   PubMed=10339589; DOI=10.1073/pnas.96.11.6341;
RA   Yamadori T., Baba Y., Mastushita M., Hashimoto S., Kurosaki M.,
RA   Kurosaki T., Kishimoto T., Tsukada S.;
RT   "Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-
RT   SH3 domain-binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6341-6346(1999).
RN   [8]
RP   INTERACTION WITH MAPK8; MAPK9 AND MAPK10, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LEU-347; LEU-349; LEU-434 AND LEU-436.
RX   PubMed=12167088; DOI=10.1042/bj20020553;
RA   Wiltshire C., Matsushita M., Tsukada S., Gillespie D.A., May G.H.;
RT   "A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5),
RT   associates with mitochondria.";
RL   Biochem. J. 367:577-585(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   INTERACTION WITH RAB11A, AND FUNCTION.
RX   PubMed=26506309; DOI=10.1016/j.devcel.2015.09.013;
RA   Sakaguchi A., Sato M., Sato K., Gengyo-Ando K., Yorimitsu T., Nakai J.,
RA   Hara T., Sato K., Sato K.;
RT   "REI-1 is a guanine nucleotide exchange factor regulating RAB-11
RT   localization and function in C. elegans embryos.";
RL   Dev. Cell 35:211-221(2015).
RN   [15] {ECO:0007744|PDB:6DJL}
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 1-265 IN COMPLEX WITH RAB11A,
RP   FUNCTION, COILED COIL, DOMAIN, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   52-LEU--GLN-54 AND 250-LEU-GLU-251.
RX   PubMed=30217979; DOI=10.1038/s41467-018-06196-z;
RA   Jenkins M.L., Margaria J.P., Stariha J.T.B., Hoffmann R.M., McPhail J.A.,
RA   Hamelin D.J., Boulanger M.J., Hirsch E., Burke J.E.;
RT   "Structural determinants of Rab11 activation by the guanine nucleotide
RT   exchange factor SH3BP5.";
RL   Nat. Commun. 9:3772-3772(2018).
CC   -!- FUNCTION: Functions as guanine nucleotide exchange factor (GEF) with
CC       specificity for RAB11A and RAB25 (PubMed:26506309, PubMed:30217979).
CC       Inhibits the auto- and transphosphorylation activity of BTK. Plays a
CC       negative regulatory role in BTK-related cytoplasmic signaling in B-
CC       cells. May be involved in BCR-induced apoptotic cell death.
CC       {ECO:0000269|PubMed:10339589, ECO:0000269|PubMed:26506309,
CC       ECO:0000269|PubMed:30217979, ECO:0000269|PubMed:9571151}.
CC   -!- SUBUNIT: Interacts with BTK (PubMed:9571151, PubMed:10339589).
CC       Interacts with all isoforms of MAPK8, MAPK9, MAPK10 and MAPK12
CC       (PubMed:12167088). Interacts with GDP-bound and nucleotide-free forms
CC       of RAB11A (PubMed:26506309, PubMed:30217979).
CC       {ECO:0000269|PubMed:10339589, ECO:0000269|PubMed:12167088,
CC       ECO:0000269|PubMed:26506309, ECO:0000269|PubMed:30217979,
CC       ECO:0000269|PubMed:9571151}.
CC   -!- INTERACTION:
CC       O60239; Q06187: BTK; NbExp=4; IntAct=EBI-624860, EBI-624835;
CC       O60239; Q9NRI5: DISC1; NbExp=3; IntAct=EBI-624860, EBI-529989;
CC       O60239; Q8IY31-3: IFT20; NbExp=3; IntAct=EBI-624860, EBI-9091197;
CC       O60239; Q9ULW6: NAP1L2; NbExp=3; IntAct=EBI-624860, EBI-3911716;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:30217979}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:30217979}. Mitochondrion
CC       {ECO:0000269|PubMed:12167088}. Note=Colocalizes with RAB11A on
CC       cytoplasmic vesicle membranes. {ECO:0000269|PubMed:30217979}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60239-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60239-2; Sequence=VSP_042854;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis and ovaries. It is also
CC       expressed in a variety of tissues including spleen, lymph node, thymus,
CC       bone marrow, fetal liver, colon, small intestine and prostate.
CC       {ECO:0000269|PubMed:9571151}.
CC   -!- DOMAIN: The N-terminal half of the protein mediates interaction with
CC       RAB11A and functions as guanine nucleotide exchange factor. Four long
CC       alpha-helices (interrupted by a central kink) assemble into coiled
CC       coils, giving rise to a 'V' shape. {ECO:0000269|PubMed:30217979}.
CC   -!- SIMILARITY: Belongs to the SH3BP5 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25922.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK090524; BAG52178.1; -; mRNA.
DR   EMBL; AC087590; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117422; CAI46220.1; -; mRNA.
DR   EMBL; CH471055; EAW64225.1; -; Genomic_DNA.
DR   EMBL; BC010123; AAH10123.2; -; mRNA.
DR   EMBL; AB005047; BAA25922.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2625.2; -. [O60239-1]
DR   CCDS; CCDS43055.1; -. [O60239-2]
DR   PIR; JE0086; JE0086.
DR   RefSeq; NP_001018009.2; NM_001018009.3. [O60239-2]
DR   RefSeq; NP_004835.2; NM_004844.4. [O60239-1]
DR   RefSeq; XP_016863011.1; XM_017007522.1. [O60239-2]
DR   RefSeq; XP_016863012.1; XM_017007523.1. [O60239-2]
DR   RefSeq; XP_016863013.1; XM_017007524.1. [O60239-2]
DR   RefSeq; XP_016863014.1; XM_017007525.1. [O60239-2]
DR   PDB; 4H3B; X-ray; 2.08 A; B/D=341-350.
DR   PDB; 6DJL; X-ray; 3.10 A; B/C/D/E=1-265.
DR   PDB; 6IXE; X-ray; 3.35 A; A=41-266.
DR   PDB; 6IXF; X-ray; 3.60 A; A/B=41-266.
DR   PDB; 6IXG; X-ray; 3.80 A; A/B=41-266.
DR   PDB; 6IXV; X-ray; 3.80 A; A/B/C/D=10-276.
DR   PDBsum; 4H3B; -.
DR   PDBsum; 6DJL; -.
DR   PDBsum; 6IXE; -.
DR   PDBsum; 6IXF; -.
DR   PDBsum; 6IXG; -.
DR   PDBsum; 6IXV; -.
DR   SMR; O60239; -.
DR   BioGRID; 114853; 23.
DR   ELM; O60239; -.
DR   IntAct; O60239; 22.
DR   STRING; 9606.ENSP00000373301; -.
DR   iPTMnet; O60239; -.
DR   PhosphoSitePlus; O60239; -.
DR   BioMuta; SH3BP5; -.
DR   EPD; O60239; -.
DR   jPOST; O60239; -.
DR   MassIVE; O60239; -.
DR   MaxQB; O60239; -.
DR   PaxDb; O60239; -.
DR   PeptideAtlas; O60239; -.
DR   PRIDE; O60239; -.
DR   ProteomicsDB; 49268; -. [O60239-1]
DR   ProteomicsDB; 49269; -. [O60239-2]
DR   TopDownProteomics; O60239-1; -. [O60239-1]
DR   Antibodypedia; 26718; 157 antibodies.
DR   DNASU; 9467; -.
DR   Ensembl; ENST00000383791; ENSP00000373301; ENSG00000131370. [O60239-1]
DR   Ensembl; ENST00000408919; ENSP00000386231; ENSG00000131370. [O60239-2]
DR   Ensembl; ENST00000426925; ENSP00000388553; ENSG00000131370. [O60239-2]
DR   GeneID; 9467; -.
DR   KEGG; hsa:9467; -.
DR   UCSC; uc003bzp.3; human. [O60239-1]
DR   CTD; 9467; -.
DR   DisGeNET; 9467; -.
DR   GeneCards; SH3BP5; -.
DR   HGNC; HGNC:10827; SH3BP5.
DR   HPA; ENSG00000131370; Low tissue specificity.
DR   MIM; 605612; gene.
DR   neXtProt; NX_O60239; -.
DR   OpenTargets; ENSG00000131370; -.
DR   PharmGKB; PA35735; -.
DR   VEuPathDB; HostDB:ENSG00000131370.15; -.
DR   eggNOG; KOG2008; Eukaryota.
DR   GeneTree; ENSGT00390000018500; -.
DR   HOGENOM; CLU_048895_1_0_1; -.
DR   InParanoid; O60239; -.
DR   OMA; QFPPATR; -.
DR   PhylomeDB; O60239; -.
DR   TreeFam; TF105573; -.
DR   PathwayCommons; O60239; -.
DR   SignaLink; O60239; -.
DR   SIGNOR; O60239; -.
DR   BioGRID-ORCS; 9467; 9 hits in 1000 CRISPR screens.
DR   ChiTaRS; SH3BP5; human.
DR   GeneWiki; SH3BP5; -.
DR   GenomeRNAi; 9467; -.
DR   Pharos; O60239; Tbio.
DR   PRO; PR:O60239; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; O60239; protein.
DR   Bgee; ENSG00000131370; Expressed in metanephros and 249 other tissues.
DR   ExpressionAtlas; O60239; baseline and differential.
DR   Genevisible; O60239; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; IDA:MGI.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:MGI.
DR   GO; GO:0061099; P:negative regulation of protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   DisProt; DP02850; -.
DR   IDEAL; IID00507; -.
DR   InterPro; IPR007940; SH3BP5.
DR   PANTHER; PTHR19423; PTHR19423; 2.
DR   Pfam; PF05276; SH3BP5; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Cytoplasmic vesicle;
KW   Guanine-nucleotide releasing factor; Membrane; Mitochondrion;
KW   Phosphoprotein; Reference proteome; SH3-binding.
FT   CHAIN           1..455
FT                   /note="SH3 domain-binding protein 5"
FT                   /id="PRO_0000064368"
FT   REGION          31..265
FT                   /note="Sufficient for interaction with RAB11A and for
FT                   guanine nucleotide exchange activity"
FT                   /evidence="ECO:0000269|PubMed:30217979"
FT   COILED          44..90
FT                   /evidence="ECO:0000269|PubMed:30217979"
FT   COILED          97..145
FT                   /evidence="ECO:0000269|PubMed:30217979"
FT   COILED          154..200
FT                   /evidence="ECO:0000269|PubMed:30217979"
FT   COILED          211..255
FT                   /evidence="ECO:0000269|PubMed:30217979"
FT   COMPBIAS        11..67
FT                   /note="Glu-rich"
FT   COMPBIAS        36..40
FT                   /note="Poly-Glu"
FT   COMPBIAS        278..421
FT                   /note="Ser-rich"
FT   COMPBIAS        405..410
FT                   /note="Poly-Ser"
FT   MOD_RES         351
FT                   /note="Phosphoserine; by MAPK12 and MAPK9"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Y80"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z131"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z131"
FT   MOD_RES         418
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Y80"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..157
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042854"
FT   MUTAGEN         52..54
FT                   /note="LNQ->AAA: Loss of guanine nucleotide exchange factor
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:30217979"
FT   MUTAGEN         250..251
FT                   /note="LE->AK: Loss of guanine nucleotide exchange factor
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:30217979"
FT   MUTAGEN         347
FT                   /note="L->A: Loss of phosphorylation and binding by
FT                   phospho-JNK; when associated with A-349."
FT                   /evidence="ECO:0000269|PubMed:12167088"
FT   MUTAGEN         349
FT                   /note="L->A: Loss of phosphorylation and binding by
FT                   phospho-JNK; when associated with A-347."
FT                   /evidence="ECO:0000269|PubMed:12167088"
FT   MUTAGEN         434
FT                   /note="L->A: No change of phosphorylation or binding by
FT                   phospho-JNK; when associated with A-436."
FT                   /evidence="ECO:0000269|PubMed:12167088"
FT   MUTAGEN         436
FT                   /note="L->A: No change of phosphorylation or binding by
FT                   phospho-JNK; when associated with A-434."
FT                   /evidence="ECO:0000269|PubMed:12167088"
FT   HELIX           44..91
FT                   /evidence="ECO:0007744|PDB:6DJL"
FT   TURN            93..95
FT                   /evidence="ECO:0007744|PDB:6DJL"
FT   HELIX           96..98
FT                   /evidence="ECO:0007744|PDB:6DJL"
FT   HELIX           99..145
FT                   /evidence="ECO:0007744|PDB:6DJL"
FT   HELIX           147..151
FT                   /evidence="ECO:0007744|PDB:6DJL"
FT   HELIX           153..200
FT                   /evidence="ECO:0007744|PDB:6DJL"
FT   HELIX           202..260
FT                   /evidence="ECO:0007744|PDB:6DJL"
SQ   SEQUENCE   455 AA;  50425 MW;  5C8CA4861D66346B CRC64;
     MDAALKRSRS EEPAEILPPA RDEEEEEEEG MEQGLEEEEE VDPRIQGELE KLNQSTDDIN
     RRETELEDAR QKFRSVLVEA TVKLDELVKK IGKAVEDSKP YWEARRVARQ AQLEAQKATQ
     DFQRATEVLR AAKETISLAE QRLLEDDKRQ FDSAWQEMLN HATQRVMEAE QTKTRSELVH
     KETAARYNAA MGRMRQLEKK LKRAINKSKP YFELKAKYYV QLEQLKKTVD DLQAKLTLAK
     GEYKMALKNL EMISDEIHER RRSSAMGPRG CGVGAEGSST SVEDLPGSKP EPDAISVASE
     AFEDDSCSNF VSEDDSETQS VSSFSSGPTS PSEMPDQFPA VVRPGSLDLP SPVSLSEFGM
     MFPVLGPRSE CSGASSPECE VERGDRAEGA ENKTSDKANN NRGLSSSSGS GGSSKSQSST
     SPEGQALENR MKQLSLQCSK GRDGIIADIK MVQIG
//
